SYRS - Syros prices capital raise of $45.0 million via securities offering
2023-12-19 07:49:27 ET
More on Syros Pharmaceuticals
- Syros jumps after Phase 2 data for leukemia therapy
- Syros Pharmaceuticals GAAP EPS of -$1.43 misses by $0.29, revenue of $3.76M misses by $0.18M
- Seeking Alpha’s Quant Rating on Syros Pharmaceuticals
- Historical earnings data for Syros Pharmaceuticals
For further details see:
Syros prices capital raise of $45.0 million via securities offering